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Abstract
Proton therapy is a rapidly progressing field for cancer treatment. Globally, many proton
therapy facilities are being commissioned or under construction. Secondary neutrons are an
important issue during the commissioning process of a proton therapy facility. The purpose
of this study is to model and validate scanning nozzles of proton therapy at Samsung Medi-
cal Center (SMC) by Monte Carlo simulation for beam commissioning. After the commis-
sioning, a secondary neutron ambient dose from proton scanning nozzle (Gantry 1) was
simulated and measured. This simulation was performed to evaluate beam properties such
as percent depth dose curve, Bragg peak, and distal fall-off, so that they could be verified
with measured data. Using the validated beam nozzle, the secondary neutron ambient dose
was simulated and then compared with the measured ambient dose from Gantry 1. We cal-
culated secondary neutron dose at several different points. We demonstrated the validity
modeling a proton scanning nozzle system to evaluate various parameters using FLUKA.
The measured secondary neutron ambient dose showed a similar tendency with the simula-
tion result. This work will increase the knowledge necessary for the development of radiation
safety technology in medical particle accelerators.
1. Introduction
Proton therapy is a rapidly expanding field of cancer treatment [1, 2]. The protons have poten-
tial advantages of delivering higher dose to the cancer and lower dose to the normal surround-
ing tissue. This highly precise localization is achieved by the Bragg peak effect, which allows a
sharp distal fall-off depth dose distribution [3]. For the above reasons, proton therapy facilities
are being construction globally, and there will be more than 100 proton therapy centers glob-
ally within a few years.
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Although proton therapy itself has outstanding physical advantages over X-ray treatment,
there are some problems and limitations [4–5]. One of the main problems is the production of
secondary neutrons when the protons undergo nuclear interactions with patients or compo-
nents inside the nozzle [5]. The secondary neutrons that are generated from protons have a
higher Relative Biological Effectiveness than photons [6–7]. Therefore, side effects to the
patient may occur. For instance, the secondary neutron is one of the factors that increase the
integral dose, which can lead to the patient’s secondary cancer [8].
There have been a variety of studies related to the induced secondary neutrons during pro-
ton therapy [9–12]. Proton therapy centers have reported simulated and experimental results
regarding induced secondary neutrons. It is difficult to directly compare the results from dif-
ferent centers because each treatment center has their own proton facility design and beam
conditions. Because the nozzle design would be changed according to the purpose even in the
same scanning nozzle, it is necessary to consider the neutron dose that is caused by the differ-
ences between each proton nozzle.
In this study, the production of secondary neutrons was evaluated for two different gantries
in the same scanning mode. First of all, proton therapy scanning nozzles were modeled by
using FLUKA Monte Carlo code [13], and then we performed the analysis of the induced sec-
ondary neutrons from Gantry 1. After beam properties of each nozzle were validated, simula-
tions and experiments were performed to evaluate the induced secondary neutrons from the
nozzles according to detector position.
2. Materials and methods
2.1 Validation of proton beam properties
In the Samsung Medical Center (SMC), there are two fully rotating gantries with different noz-
zles, which utilize protons that can be accelerated up to 230 MeV using a conventional cyclo-
tron. Table 1 shows properties of the different nozzles. Gantry 1 can be operated in wobbling
and scanning modes, but Gantry 2 employs the scanning mode only. Gantry 1 can operate in a
similar mode to the scanning mode of Gantry 2, but does not contain a pipe through which He
gas pipe can be added [14]. The helium gas pipe reduces the proton beam penumbra.
Fig 1 shows a schematic of the proton therapy facilities at SMC and Fig 2 indicates the scan-
ning mode nozzles that were modeled using FLUKA simulation to verify the beam properties.
Table 1. Explanation of the different proton nozzles at SMC.
Nozzle Type Explanation / Principle
Gantry 1: Multipurpose nozzle Wobbling
mode
- For wobbling mode operation, the two x and y wobbling
magnets will widen the proton beam, which will then pass
through the scatterer to form a two-dimensional dose
distribution, which is the actual field size.
- To deliver the correct depth of dose to the tumor, the
ridge filter forms a spread-out Bragg peak by alternating
the pristine Bragg peak.
Gantry 2: Pencil Beam
Scanning dedicated nozzle
Scanning
mode
- Several components used for the wobbling mode are not
required, such as the wobbling magnets, scatterers, ridge
filters, MLC, and compensator.
- In the PBS dedicated nozzle, there are far fewer
components, which include a scanning magnet, He gas
duct, and aperture.
- The difference between scanning with multipurpose and
PBS dedicated nozzle is the existence of other nozzle
components, especially the MLC and He gas pipe.
https://doi.org/10.1371/journal.pone.0186544.t001
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For both types of nozzle, FLUKA simulation was carried out. However, the experimental mea-
surement was only performed at Gantry 1. To validate the proton therapy scanning nozzles of
Gantries 1 and 2 in the scanning mode at SMC, we performed modeling using FLUKA Monte
Carlo simulation code. Monte Carlo studies were performed using geometry information of
the two different nozzles provided by the nozzle manufacturer.
Fig 1. Schematic of SMC proton therapy facility.
https://doi.org/10.1371/journal.pone.0186544.g001
Fig 2. Design of each scanning nozzle using Monte Carlo simulation FLUKA.
https://doi.org/10.1371/journal.pone.0186544.g002
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In this study, the neutron detector was modeling by WENDI-2 detector (Wide Energy Neu-
tron Detection Instrument, Thermo Scientific, USA). Fig 3 depicts WENDI-2 detector. To val-
idate simulation system, the Monte Carlo simulation was performed evaluating proton beam
properties such as the Bragg peak, distal fall-off, R90, R10, and spot size of the beam based on
experimental beam data. Fig 4 is explained used beam parameters for the proton beam proper-
ties. A 40 × 40 × 40 cm of plastic water phantom was placed around the gantry radially from 0˚
to 270˚ with 30 different beam energies from 70 MeV to 230 MeV.
Fig 3. Feature of the WENDI-2 detector and its Schematic modeled in Monte Carlo simulation. (Left) The
WENDI-2 neutron detector used for measurement of secondary neutron flux (Thermo Scientific), (Right)
Schematic of the WENDI-2 detector structure that modeled in FLUKA simulation.
https://doi.org/10.1371/journal.pone.0186544.g003
Fig 4. Parameters for data analysis of beam properties.
https://doi.org/10.1371/journal.pone.0186544.g004
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To obtain experimental results, we are performed measurement using Zebra (IBA), water
phantom and ion chamber in same simulation conditions. Fig 5 shows the experiment figure
to obtain proton beam properties.
2.2 Measurement of secondary neutrons generated by each nozzle
The secondary neutrons are produced by the nuclear interactions with the material in the
beam path during treatment. This issue remains an unavoidable problem of any proton
therapy technique including wobbling, scattering, and scanning. Although secondary neu-
tron exposure is relatively low to compare with the therapeutic protons, the secondary neu-
trons provide a significant contribution to the integral dose and may cause secondary cancer
[15–16].
There are two sources of secondary neutron in proton therapy: external neutrons from
other materials and internal neutrons generated inside the patients. The external neutrons are
dependent on the design of the proton therapy nozzle and treatment devices within the beam
line. On the other hand, the internal neutrons are dependent on the beam range and field size
in the patient. In the secondary neutron measurement, sum of the two sources are shown as
the ambient neutron dose at any adjacent positions. Therefore, only external neutron dose can
be measured when phantom is not installed on the beam line. In other words, the influence of
the internal neutron dose can be derived when phantom is located after the external neutron
dose has been measured.
In this study, we measured ambient neutron dose during the scanning mode proton ther-
apy with Gantry 1 using a WENDI-2 neutron detector in both simulation and experiment. In
this simulation, the wall of therapy room was not considered and the effect was neglected. To
determine the dose contribution from only the external neutrons, the secondary neutron dose
was measured at 4 positions (x-axis off set -44.29 cm, -16.43 cm, 16.43 cm and 44.29 cm) with-
out the phantom. An irradiation of 110 MeV of proton energy was produced by Gantry 1.
Fig 5. Experiment equipment to obtain proton beam properties. (Left) Installation of the ion chamber on the patient table to measure the
Bragg peak, R90, R10 and distal fall-off (Zebra multi-layer ion chamber, IBA Inc.), (Right) Installation of the ion chamber in the water phantom
for beam spot size measurement.
https://doi.org/10.1371/journal.pone.0186544.g005
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After the external neutron has been evaluated by the ambient neutron dose, a 30 × 30 × 30
cm of plastic water phantom was positioned at the isocenter to investigate the influence of the
internal neutron dose. Fig 6 shows the simulation design of Gantries 1 and 2. In the experiment,
the measurement was performed at Gantry 1 with an identical condition of the simulation. Fig 7
Fig 7. WENDI-2 detector location for secondary neutron dose measurement. x-axis offset of (A) 44.29 cm, (B)
16.43 cm, (C) -16.43 cm and (D) -44.29 cm, respectively.
https://doi.org/10.1371/journal.pone.0186544.g007
Fig 6. Measurement of secondary neutrons in each gantry by FLUKA.
https://doi.org/10.1371/journal.pone.0186544.g006
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shows the experimental setup for measurement of the external secondary neutron from the
scanning nozzle.
3. Results and discussion
3.1 Proton scanning validation using Monte Carlo simulation
We designed and simulated the two different proton therapy nozzles at SMC. Figs 8 and 9
show the difference of beam properties between the simulation data and experimental data at
Gantries 1 and 2, respectively. Fig 8 shows the result of beam properties that compared the
experimental data and simulation data at gantry 1 scanning nozzle. Also, Fig 9 shows the result
at scanning nozzle of gantry 2. The difference between the experimental data and Monte Carlo
beam validation results of Bragg peak, R90, R10, and distal fall-off are less than 1 mm. Addition-
ally, Fig 10 indicates that the difference of beam spot size in terms of the FWHM is less than
0.5 mm at both Gantries 1 and 2. In the difference comparison, the simulation result show an
agreement with the experimental data within 2.5% of error range.
3.2 Measurement of the secondary neutron from each nozzle
To distinguish between internal and external neutrons, Monte Carlo code was used to simu-
late the delivery of the proton beam with and without a phantom. The neutron detector was
simulated as a WENDI-2. Figs 11 and 12 show simulation results of the detected value of
ambient neutron dose with beam energies of 110 and 190 MeV, respectively. Also, Figs 11
and 12 indicate ambient neutron doses normalized to the maximum value at the gantry 1
and 2, respectively.
Fig 8. Gantry 1 results: 1) Bragg peak, 2) R90, 3) R10, and 4) distal fall-off.
https://doi.org/10.1371/journal.pone.0186544.g008
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The normalized neutron flux at Gantry 1 is higher than the flux of Gantry 2, and the results
at positions 1 and 4 show similar tendencies because detectors are located symmetrically from
the isocenter, as do those at positions 2 and 3. For positions 1 and 4, the neutron dose with
phantom is higher than the dose without phantom because internal neutrons from the phan-
tom are produced in addition to the external neutrons.
3.3 Comparison between Monte Carlo simulations and experimental
measurements
To compare the simulated and experimentally measured ambient neutrons dose at Gantry 1 in
the same conditions, the secondary neutrons ambient dose was measured using the WENDI-2
Fig 9. Gantry 2 results: 1) Bragg peak, 2) R90, 3) R10, and 4) distal fall-off.
https://doi.org/10.1371/journal.pone.0186544.g009
Fig 10. Results from Gantries 1(Left) and 2(Right) of FWHM of beam spot size.
https://doi.org/10.1371/journal.pone.0186544.g010
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detector. The secondary neutron dose was measured at 4 positions without a phantom with a
110 MeV proton beam. Fig 13 shows the comparison of the ambient neutron dose acquired
from the simulation and experiment. The results were normalized to the maximum value of
the experiment. The experimental and simulation values show similar tendency that the num-
ber of external neutrons reduces as the detection distance from the isocenter is increased. Also,
the results at positions 1 and 4 show similar tendencies because detectors are located symmet-
rically from the isocenter, as do those at positions 2 and 3. These results prove that the simula-
tion data provides reliable data of the induced neutron dose
Fig 11. Normalized secondary neutron dose from 110 MeV proton beam at Gantries 1 and 2 from Monte Carlo simulation.
https://doi.org/10.1371/journal.pone.0186544.g011
Fig 12. Normalized secondary neutron dose from 190 MeV proton beam at Gantries 1 and 2 from Monte Carlo simulation.
https://doi.org/10.1371/journal.pone.0186544.g012
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4. Conclusions
In this study, we evaluated secondary neutron production from the proton beam-scanning
nozzle. In order to assess the secondary neutron production, we modeled the proton scanning
nozzle system using FLUKA Monte Carlo simulation and verified its validity. The verification
process was that comparison beam properties achieved from the simulation and experiment in
terms of the Bragg peak, R90, R10, distal fall-off and FWHM of the beam spot size. After the
FLUKA modeling was confirmed, the secondary neutron production was measured by the sec-
ondary neutron dose from the simulation and experiment, respectively. As results of the beam
properties comparison, the proton scanning nozzle modeling using FLUKA simulation was
verified that describes the actual scanning nozzle with the high precision. Using the validated
nozzle modeling, the amount of secondary neutron production was estimated and compared
to the experimental result. The result can be utilized to the further study which considers the
shielding material design for secondary neutron reduction. In other words, the amount of sec-
ondary neutron production which is reduced depending on the shielding material design can
be predicted by using the FLUKA simulation modeling. In addition, these results will contrib-
ute to provide the knowledge for the development of radiation safety technology in medical
particle accelerators.
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